BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $138 at Jefferies
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $67.85 +1.82%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 12 | New: 26
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 12 | New: 26
Join SI Premium – FREE
Jefferies analyst Eun Yang raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $138.00 (from $132.00) while maintaining a Buy rating.
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $88 at Piper Sandler
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Amgen (AMGN) PT Raised to $400 at Cantor Fitzgerald on Higher Sales Estimates
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
